The U.S. government is poised to exert significant control over the release of AI models.
In recent developments, shortly after the U.S. government halted the rollout of Anthropic’s Fable and Mythos models, it appears OpenAI’s latest model might face a similar fate. According to reports, OpenAI’s GPT 5.6 is slated for a limited preview, with the government approving its release on a “customer by customer” basis until a broader release can be authorized.
Should this preview phase last only a few weeks, as predicted by Altman, it might not pose a significant issue. However, considering that Mythos has lingered in preview for months without clear indicators of a general release, even a brief delay could severely impact the economic viability of a high-investment system. This concern looms large as AI firms strive to boost their financial performance. A slowdown in model development could also hinder ongoing expansions in data center capacity.
If such scenarios unfold unfavorably, the ramifications for the entire industry could be dire.
Both OpenAI and Anthropic now find themselves in similar predicaments, facing identical challenges and potential disasters if they falter. Discussions within the technology sector often revolve around blame—either pointing fingers at Anthropic for alleged regulatory manipulation or accusing OpenAI of political favoritism to eliminate competition. Such perspectives are understandable, considering many influential figures have substantial financial stakes tied to one entity or the other.
Yet, the current situation transcends individual interests. The ramifications of imposing a chaotic government sanction process for every cutting-edge model are evident, and solutions beneficial for one lab cannot be exclusive to it.
The pressing concern is devising a sensible release framework. While it is reasonable for the government to evaluate models before they hit the market—akin to the processes in many consumer sectors—questions linger about the feasibility of ensuring adequate safety measures to meet regulatory expectations. As noted by Dean Ball, a GMU fellow and future OpenAI employee, the government lacks the specialized knowledge and capacity for the testing that would be required. Additionally, it remains ambiguous what specific risks regulators aim to mitigate, given the absence of clear articulation regarding governmental concerns.
Though it might be easy to view the government’s process as a pivotal issue, there are deeper problems at play. Even skeptics of Mythos recognition cannot ignore the transformative effects AI tools are having in fields like cybersecurity. Similar transformations are seen in biorisk management and alignment. Simply imposing restrictions on model releases cannot serve as a comprehensive solution; such measures would only diminish public access to technological advancements while failing to address genuine concerns.
As outlined by Ball, the most promising strategies to tackle these issues necessitate collaboration. This entails trusting independent organizations to navigate the processes, even if they do not fully align with one’s objectives. Embracing the least detrimental regulatory approaches rather than resisting every regulation is essential. Above all, it demands advocating for the AI sector collectively instead of viewing safety regulations solely as opportunities for competitive advantage.
For many professionals in the AI field, rallying support for such perspectives may prove challenging. Unfortunately, AI models have evolved to a stage where their capabilities bear significant political implications. Addressing these ramifications will require unified efforts. In the upcoming weeks, we will see if the industry is prepared to undertake this challenge.
